These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8610366)

  • 1. Administration of rabbit anti-asialo GM1 antiserum facilitates the development of human Epstein-Barr virus-induced lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Jagiello C; O'Reilly RJ
    Transplantation; 1996 Feb; 61(3):492-7. PubMed ID: 8610366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes home preferentially to and induce selective regressions of autologous EBV-induced B cell lymphoproliferations in xenografted C.B-17 scid/scid mice.
    Lacerda JF; Ladanyi M; Louie DC; Fernandez JM; Papadopoulos EB; O'Reilly RJ
    J Exp Med; 1996 Mar; 183(3):1215-28. PubMed ID: 8642263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.
    Shpitz B; Chambers CA; Singhal AB; Hozumi N; Fernandes BJ; Roifman CM; Weiner LM; Roder JC; Gallinger S
    J Immunol Methods; 1994 Feb; 169(1):1-15. PubMed ID: 7907638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice.
    Yoshino H; Ueda T; Kawahata M; Kobayashi K; Ebihara Y; Manabe A; Tanaka R; Ito M; Asano S; Nakahata T; Tsuji K
    Bone Marrow Transplant; 2000 Dec; 26(11):1211-6. PubMed ID: 11149733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted i.p. with EBV-seropositive human peripheral blood lymphocytes.
    Baiocchi RA; Caligiuri MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5577-81. PubMed ID: 7911241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells or active Epstein-Barr virus infection in the development of lymphoproliferative disease in human B cell-injected severe combined immunodeficient mice.
    Coles RE; Boyle TJ; DiMaio JM; Berend KR; Via DF; Lyerly HK
    Ann Surg Oncol; 1994 Sep; 1(5):405-10. PubMed ID: 7531601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.
    Saijo N; Ozaki A; Beppu Y; Takahashi K; Fujita J; Sasaki Y; Nomori H; Kimata M; Shimizu E; Hoshi A
    J Cancer Res Clin Oncol; 1984; 107(3):157-63. PubMed ID: 6736102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
    Yoshioka T; Sato S; Fujiwara H; Hamaoka T
    Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell- injected scid mice. II. Role of host and donor factors in tumor generation.
    Veronesi A; Coppola V; Veronese ML; Menin C; Bruni L; D'Andrea E; Mion M; Amadori A; Chieco-Bianchi L
    Int J Cancer; 1994 Dec; 59(5):676-83. PubMed ID: 7960241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective depletion of NK cell activity in vivo and its effect on the growth of NK-sensitive and NK-resistant tumor cell variants.
    Kawase I; Urdal DL; Brooks CG; Henney CS
    Int J Cancer; 1982 May; 29(5):567-74. PubMed ID: 7095901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
    Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man.
    Rowe M; Young LS; Crocker J; Stokes H; Henderson S; Rickinson AB
    J Exp Med; 1991 Jan; 173(1):147-58. PubMed ID: 1845872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.
    Habu S; Fukui H; Shimamura K; Kasai M; Nagai Y; Okumura K; Tamaoki N
    J Immunol; 1981 Jul; 127(1):34-8. PubMed ID: 7240748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
    Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-asialo GM1 antibody suppression of cyclophosphamide-induced diabetes in NOD mice.
    Maruyama T; Watanabe K; Takei I; Kasuga A; Shimada A; Yanagawa T; Kasatani T; Suzuki Y; Kataoka K; Saruta
    Diabetes Res; 1991 May; 17(1):37-41. PubMed ID: 1823558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful engraftment of human postnatal thymus in severe combined immune deficient (SCID) mice: differential engraftment of thymic components with irradiation versus anti-asialo GM-1 immunosuppressive regimens.
    Barry TS; Jones DM; Richter CB; Haynes BF
    J Exp Med; 1991 Jan; 173(1):167-80. PubMed ID: 1985120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
    Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
    J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glycolipid on the surface of mouse natural killer cells.
    Kasai M; Iwamori M; Nagai Y; Okumura K; Tada T
    Eur J Immunol; 1980 Mar; 10(3):175-80. PubMed ID: 6966574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorder.
    Baiocchi RA; Ward JS; Carrodeguas L; Eisenbeis CF; Peng R; Roychowdhury S; Vourganti S; Sekula T; O'Brien M; Moeschberger M; Caligiuri MA
    J Clin Invest; 2001 Sep; 108(6):887-94. PubMed ID: 11560958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
    Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
    J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.